ASCO: Combo Tx Feasible in Residual Ovarian Cancer (CME/CE)

(MedPage Today) -- IP carboplatin plus dose-dense IV paclitaxel seems safe, effective
Source: MedPage Today Meeting Coverage - Category: Journals (General) Source Type: news